Characterization of Crohn disease in X-linked inhibitor of apoptosis–deficient male patients and female symptomatic carriers
- 1 November 2014
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 134 (5) , 1131-1141.e9
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel diseaseNature Genetics, 2011
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiencyJournal of Immunological Methods, 2010
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 ReceptorNew England Journal of Medicine, 2009
- XIAP mediates NOD signaling via interaction with RIP2Proceedings of the National Academy of Sciences, 2009
- Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's diseaseJournal of Experimental Medicine, 2009
- XIAP as a ubiquitin ligase in cellular signalingCell Death & Differentiation, 2009
- A Crohn's disease–associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1Nature Immunology, 2009
- Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the familyEMBO Reports, 2006